Long-term effects of caffeine therapy for apnea of prematurity.
about
Pentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsPentoxifylline for the prevention of bronchopulmonary dysplasia in preterm infantsMethylxanthine treatment for apnoea in preterm infantsProphylactic methylxanthines for endotracheal extubation in preterm infantsProphylactic methylxanthine for prevention of apnoea in preterm infantsCarnitine supplementation for preterm infants with recurrent apnoeaProphylactic methylxanthines for extubation in preterm infantsLosing sleep over the caffeination of prematurityPharmacologic interventions for the prevention and treatment of retinopathy of prematurityCaffeine therapy in preterm infantsAn update on pharmacologic approaches to bronchopulmonary dysplasiaIntermittent hypoxic episodes in preterm infants: do they matter?Early Caffeine Use in Very Low Birth Weight Infants and Neonatal Outcomes: A Systematic Review and Meta-AnalysisHypoxic Episodes in Bronchopulmonary DysplasiaNeuroprotection by Caffeine in Hyperoxia-Induced Neonatal Brain InjuryAdenosine receptors as drug targets--what are the challenges?Effects of caffeine treatment for apnea of prematurity on cortical speech-sound differentiation in preterm infants.Ethnobotany as a pharmacological research tool and recent developments in CNS-active natural products from ethnobotanical sources.Effects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn ratsChronic lung disease and developmental delay at 2 years of age in children born before 28 weeks' gestation.Developmental outcomes of very preterm infants with tracheostomies.The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.Reducing the incidence of chronic lung disease in very premature infants with aminophylline.Therapeutic effect of caffeine treatment immediately following neonatal hypoxic-ischemic injury on spatial memory in male rats.Adenosine receptors and caffeine in retinopathy of prematurity.Methylxanthine treatment for apnea in preterm infants.Prophylactic methylxanthine for preventing of apnea in preterm infants.Feasibility of comprehensive, unattended ambulatory polysomnography in school-aged childrenDrug therapy trials for the prevention of bronchopulmonary dysplasia: current and future targetsAnti-inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide-induced amnionitisCaffeine for the management of apnea in preterm infants.Change in practice after the Surfactant, Positive Pressure and Oxygenation Randomised Trial.Caffeine modulates CREB-dependent gene expression in developing cortical neuronsGenetics of caffeine consumption and responses to caffeine.Apnea of prematurity: pathogenesis and management strategies.Apnea of prematurity: from cause to treatmentA comprehensive approach to the prevention of bronchopulmonary dysplasia.Infant flow biphasic nasal continuous positive airway pressure (BP- NCPAP) vs. infant flow NCPAP for the facilitation of extubation in infants' ≤ 1,250 grams: a randomized controlled trial.Adenosine A2A receptor contributes to ischemic brain damage in newborn piglet.Metyrapone alleviates deleterious effects of maternal food restriction on lung development and growth of rat offspring
P2860
Q24187852-30C728C4-78F9-4BA5-A317-A69AC61A2B9EQ24201869-0D65B2E4-F88B-488E-8026-8F2864279D20Q24235661-18E3CB5C-E5A4-45CC-802A-1F325E139D56Q24235753-BD39C6F2-0AC0-4FC8-A445-AC5085B9C0D1Q24235779-92051A42-F5E8-477E-AC67-68401D9139E5Q24247700-FC131A5F-0867-4768-BFE2-9727EDEA4616Q24250229-457C8D8C-1DD4-4757-A2DC-FF2030D0813EQ24657743-FB757B9E-7A77-4A90-A46F-AF0F23D44F54Q26772889-92EF5B8B-F85B-456E-8809-5A7D75E1AC5DQ26777204-8351BE12-5A26-465E-A70B-3AAECE714F69Q26825139-C902635F-835A-404C-A333-F094033C660FQ26827976-5DE2E174-1064-419A-82B3-7BD2DFDB7365Q28074483-A04D2265-D003-4FE8-808A-EF26CE2F1249Q28087614-40A0445C-C07B-4D72-A12E-D822DF2FF2E0Q29247914-615BB19B-8F69-4611-8763-D616D5B8348BQ29346491-9387C8DE-1919-4F8C-8A10-EC8779F43A07Q30389736-40DDD759-AD5C-4C09-98E9-7DA133CFCFA4Q30396823-09DB3597-D659-4954-95AC-3A648FE0BFA7Q33378441-D978ABFD-9F08-4DB9-9C51-1622ECABE652Q33561756-AB434A6F-C5AB-4784-8162-EDDE0961731DQ33670888-C37A85BF-A6AB-4B3B-997C-925A937849C8Q33711647-6A0A7C05-6F17-4056-9601-BCD369D00927Q33731016-DF5770F6-9423-42E2-B10A-58DDFFC2E1B9Q33772048-379878EC-1D35-41E6-9679-2D9E141667A8Q33860622-178F29B0-C200-4198-9CCB-BC1D6FD1B14EQ33907643-6918C8A0-F316-4E69-8AE0-FD148D5D7AAFQ33907954-D199EBF5-5FA9-4A70-A59B-98EDAB011B83Q33933789-A6236269-2068-40D7-9239-82085FB271E7Q33948552-EFB1F3B5-7EE6-4FE6-A5EE-0A57C41F1323Q34008174-1BAD9F27-AAFF-4A57-8E02-B11E53809057Q34029994-0BD8B08F-395C-4754-9509-CA3BBB61E963Q34051586-B73F4222-52D5-4ED9-AFA1-A9E03F0C4109Q34070620-BEB8F58F-5D4E-423C-B3BB-D96065E5A617Q34119748-4C75EAD6-5A94-4672-9AF2-4604639D741DQ34153141-677E2AC3-4903-4037-AC1C-167DCB6C757CQ34163237-8EB8E95C-2AD1-4497-86EC-264732FC9B09Q34205911-DA1FDD72-50F6-429B-985E-828959CB38F1Q34220161-7B27CE1A-8EC4-427B-9BBF-2D1FBD9FBD3BQ34824112-0AD884DE-E333-42AF-A406-848395FF088EQ34876125-2563E682-2211-4567-A0E8-9A123E9F45BF
P2860
Long-term effects of caffeine therapy for apnea of prematurity.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Long-term effects of caffeine therapy for apnea of prematurity.
@ast
Long-term effects of caffeine therapy for apnea of prematurity.
@en
Long-term effects of caffeine therapy for apnea of prematurity.
@nl
type
label
Long-term effects of caffeine therapy for apnea of prematurity.
@ast
Long-term effects of caffeine therapy for apnea of prematurity.
@en
Long-term effects of caffeine therapy for apnea of prematurity.
@nl
prefLabel
Long-term effects of caffeine therapy for apnea of prematurity.
@ast
Long-term effects of caffeine therapy for apnea of prematurity.
@en
Long-term effects of caffeine therapy for apnea of prematurity.
@nl
P2093
P356
P1476
Long-term effects of caffeine therapy for apnea of prematurity.
@en
P2093
Alfonso Solimano
Arne Ohlsson
Barbara Schmidt
Caffeine for Apnea of Prematurity Trial Group
Keith J Barrington
Peter Davis
Robin S Roberts
P304
P356
10.1056/NEJMOA073679
P407
P50
P577
2007-11-01T00:00:00Z